This is a good example of what the technology can really do to improve bioinformatics generation and collaboration. There are, however, few other alliances - all trying to reach the same goals and we still don't see enough applicable progress. The real value should be if applicable products are generated faster through such alliance and if the industry (pharma, biotech)/healthcare/research communities awareness will be promoted better.
Eventually, the ,market response and acceptance, on a large scale, are they keys to enable developers to continue and their companies make enough resources to support more development and gain further revenues. It is still the main challenge we are all facing at the life sciences technologies ventures.
Comments and suggestions are most welcome. Thanks!